Trends and Characteristics of Clinical Research in Vietnam from 2010 to 2024: A Descriptive Analysis of ClinicalTrials.gov Data
Research in Clinical Pharmacy · 2025
DOI: 10.59931/rcp.25.0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2025. Verfasst von Do Thuy Linh und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hai Phong University.
Abstract (Originalsprache)
Background
Over the past decade, Vietnam has witnessed substantial growth in clinical research.Despite this progress, there is a paucity of comprehensive overviews of trial characteristics and trends.This study aimed to describe the status and trends of clinical trials conducted in Vietnam between 2010 and 2024, using publicly available data from ClinicalTrials.gov.
Methods
This cross-sectional descriptive study was conducted employing data retrieved from ClinicalTrials.gov on clinical trials conducted in Vietnam between January 1, 2010 and December 31, 2024.Each trial record was manually coded based on sponsor origin, study type and phase, population, intervention, therapeutic area, and result availability.Descriptive statistics were applied, and trends were analyzed across three 5-year periods (2010-2014, 2015-2019, and 2020-2024).
Results
This study included 721 clinical trials.Interventional trials constituted 82.8% of the included trials, with Phase III trials being the most frequently reported.The number of trials increased consistently over time, rising from 141 (2010-2014) to 352 (2020-2024).Domestic sponsorship increased significantly, exceeding international sponsors in the most recent period (198 vs. 154 trials).Originally the most researched treatment area, infectious diseases gradually lost ground to oncology, cardiovascular disease, and endocrine disorders.The proportion of drug trials decreased from 53.5% to 26.7% of all interventions, while procedural and behavioral studies exhibited an upward trend.However, early-phase trials were still few, and results from only 17.9% of research were made publicly available.
Conclusion
Vietnam's clinical research landscape has expanded substantially in volume and scope, characterized by greater local engagement and a broader diversification of study focus.Nonetheless, transparency, early-phase research, and inclusion of underrepresented populations remain key areas requiring further improvement.Ongoing investment in research infrastructure and policy alignment with global standards will be crucial for sustaining progress and optimizing the impact of clinical trials in Vietnam.
Förderung
- Hai Phong University
Zitieren
APA
Linh, D. T., Mai, N. T. Q., Ngan, T. T., Anh, T. V., Linh, P. V., & Phuong, N. T. T. (2025). Trends and Characteristics of Clinical Research in Vietnam from 2010 to 2024: A Descriptive Analysis of ClinicalTrials.gov Data. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.25.0002
Vancouver
Linh DT, Mai NTQ, Ngan TT, Anh TV, Linh PV, Phuong NTT. Trends and Characteristics of Clinical Research in Vietnam from 2010 to 2024: A Descriptive Analysis of ClinicalTrials.gov Data. Research in Clinical Pharmacy. 2025. doi:10.59931/rcp.25.0002
BibTeX
@article{Linh2025,
author = {Linh, Do Thuy and Mai, Ngo Thi Quynh and Ngan, Tran Thi and Anh, Tran Van and Linh, Pham Van and Phuong, Nguyen Thi Thu},
title = {Trends and Characteristics of Clinical Research in Vietnam from 2010 to 2024: A Descriptive Analysis of ClinicalTrials.gov Data},
journal = {Research in Clinical Pharmacy},
year = {2025},
doi = {10.59931/rcp.25.0002}
}
EUVIMED